Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

TLR3 and COVID-19 are reported together in 3 articles.

Gene

TLR3

HGNC
HGNC:11849
43articles
43mentions
10variants with confirmed gene link (top 10)
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
Phenotype

COVID-19

1,317articles
1,317mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

3 records shown · first 60

Multiple inborn errors of type I IFN immunity in a 33-year-old male with a fatal case of COVID-19.

PMID 38665565 | PMCID PMC11043952 | DOI 10.1016/j.heliyon.2024.e29338 · Heliyon · 2024 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneTLR3“The three mutations were predicted to predispose to severe viral infections: monoallelic R488X TLR3, monoallelic His684Arg TLR3, and biallelic Val363Met IRF3.”0.98hgnc_dict_v1
phenotypeCOVID-19“Multiple inborn errors of type I IFN immunity in a 33-year-old male with a fatal case of COVID-19.”0.98phenotype_alias_lexicon_v2
geneIRF3“The three mutations were predicted to predispose to severe viral infections: monoallelic R488X TLR3, monoallelic His684Arg TLR3, and biallelic Val363Met IRF3.”0.98hgnc_dict_v1
variantR488X“The three mutations were predicted to predispose to severe viral infections: monoallelic R488X TLR3, monoallelic His684Arg TLR3, and biallelic Val363Met IRF3.”0.82literature_variant_regex_v2

Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.

PMID 32599245 | PMCID PMC7319641 | DOI 10.1016/j.ijbiomac.2020.06.228 · International journal of biological macromolecules · 2020 · 7 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneTLR3“We have identified significant interaction between ISGs and TLR3 agonists, like poly I: C, and imiquimod, and suggests that TLR3 agonists can be considered as a potential drug for drug repurposing in COVID-19.”0.98hgnc_dict_v1
phenotypeCOVID-19“Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.”0.98phenotype_alias_lexicon_v2
geneIFIT1“These ISGs (IFIT1, IFITM1, IRF7, ISG15, MX1, and OAS2) can be considered as potential candidates for drug targets in the treatments of COVID-19.”0.98hgnc_dict_v1
geneIFITM1“These ISGs (IFIT1, IFITM1, IRF7, ISG15, MX1, and OAS2) can be considered as potential candidates for drug targets in the treatments of COVID-19.”0.98hgnc_dict_v1

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

PMID 32972995 | PMCID PMC7857407 | DOI 10.1126/science.abd4570 · Science (New York, N.Y.) · 2020 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneTLR3“We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection.”0.98hgnc_dict_v1
phenotypeCOVID-19“Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.”0.98phenotype_alias_lexicon_v2
geneIRF7“We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection.”0.98hgnc_dict_v1
phenotypeSARS“Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease 2019 (COVID-19).”0.93phenotype_alias_lexicon_v2